Browse by Journal Title

2024

Comparison of R-CHOP-14 and R-mini-CHOP in older adults with diffuse large B-cell lymphoma - a retrospective multicenter cohort study.
Dilbaz, Z.G., Denker, S., Ankermann, C., Bittenbring, J.T., Kaddu-Mulindwa, D., Kunte, A.S., Hünecke, S., Poeschel, V., Stilgenbauer, S., Thurner, L., Na, I.K., Bewarder, M. and Christofyllakis, K.
European Journal of Haematology 113 (5): 675-684. November 2024

2019

Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies.
Na, I.K., Buckland, M., Agostini, C., Edgar, J.D.M., Friman, V., Michallet, M., Sánchez-Ramón, S., Scheibenbogen, C. and Quinti, I.
European Journal of Haematology 102 (6): 447-456. June 2019

2017

Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
Hemmati, P.G., Vuong, L.G., Terwey, T.H., Jehn, C.F., Le Coutre, P., Penack, O., Na, I.K., Dörken, B. and Arnold, R.
European Journal of Haematology 98 (2): 160-168. February 2017

2015

Allogeneic stem cell transplantation for refractory acute myeloid leukemia: a single center analysis of long-term outcome.
Hemmati, P.G., Terwey, T.H., Na, I.K., Jehn, C.F., le Coutre, P., Vuong, L.G., Doerken, B. and Arnold, R.
European Journal of Haematology 95 (6): 498-506. December 2015

Impact of early remission by induction therapy on allogeneic stem cell transplantation for acute myeloid leukemia with an intermediate risk karyotype in first complete remission.
Hemmati, P.G., Terwey, T.H., Na, I.K., le Coutre, P., Jehn, C.F., Vuong, L.G., Dörken, B. and Arnold, R.
European Journal of Haematology 94 (5): 431-438. May 2015

2014

R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma.
Kreher, S., Lammer, F., Augustin, D., Pezzutto, A. and Baldus, C.D.
European Journal of Haematology 93 (1): 70-76. July 2014

Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remission.
Hemmati, P.G., Schulze-Luckow, A., Terwey, T.H., le Coutre, P., Vuong, L.G., Doerken, B. and Arnold, R.
European Journal of Haematology 92 (2): 102-110. February 2014

2011

A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplants.
Hemmati, P.G., Terwey, T.H., le Coutre, P., Vuong, L.G., Massenkeil, G., Doerken, B. and Arnold, R.
European Journal of Haematology 86 (4): 305-316. April 2011

2010

BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients.
le Coutre, P., Reinke, P., Neuhaus, R., Trappe, R., Ringel, F., Lalancette, M., Hemmati, P.G., Doerken, B. and Daniel, P.T.
European Journal of Haematology 84 (1): 26-33. 1 January 2010

2004

Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf, M., Hecht, K., Reif, S., Pelka-Fleischer, R., Pfister, K. and Schmetzer, H.
European Journal of Haematology 72 (2): 89-106. February 2004

2003

Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk.
Graf, M., Reif, S., Hecht, K., Pelka-Fleischer, R., Pfister, K., Nuessler, V. and Schmetzer, H.
European Journal of Haematology 71 (5): 366-376. November 2003